.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

spacer.gif (423 bytes)

homer.gif (577 bytes)


Guidelines for Pharmacological Management of
Chronic Stable Angina Pectoris

Page  1  2

Angina pectoris

The term ‘angina pectoris’ is used for chest discomfort due to myocardial ischaemia associated with coronary artery disease. Angina pectoris occurs when there is an imbalance between myocardial perfusion and the demands of the myocardium. This almost always occurs as a result of narrowing of the coronary arteries due to atherosclerosis. Usually, a coronary artery must be narrowed by at least 50-70% in luminal diameter before blood flow is inadequate to meet the metabolic demands of the heart with exercise or stress.

Anginal symptoms are regarded as stable if they have been occurring over several weeks without major deterioration. They typically occur in conditions associated with increased myocardial oxygen consumption (e.g. during exercise).

Angina is said to be unstable if pre-existing angina worsens abruptly for no apparent reason or when new angina develops at a relatively low work load or at rest. This form of angina is often associated with rupture of the atherosclerotic plaque and subsequent clot formation within the coronary artery.

Angina is variant or of the Prinzmetal type if it develops spontaneously with ST elevation on the electrocardiogram. This is usually due to an increase in coronary tone or spasm.

This booklet outlines the guidelines for the pharmacological management of chronic stable angina pectoris.

 

Risk factors for angina pectoris

Non-modifiable
  • Age
  • Male gender
  • Family history of coronary heart disease

Modifiable

  • Smoking
  • High intake of alcohol
  • Hyperlipidaemia
  • Hypertension
  • Diabetes
  • Stress
  • Obesity
Symptoms

Anginal symptoms have four cardinal features:

a) Location
Discomfort is typically located in the retrosternal region (central chest region) and may radiate to both sides of the chest and the arms (more commonly the left) as far as the wrist, and to the neck and jaw. Quite frequently, the pain starts in one of the other areas and only later spreads to the central chest.

b) Relationship to exercise
Angina is provoked by exercise (or other stress) and is quickly relieved by rest. Emotions may also cause angina.

c) Character
Feeling of pressure or a strangling sensation in the chest. The intensity may vary from a slight localised discomfort to severe pain.

d) Duration
Symptoms usually spontaneously resolve within 1-3 minutes after discontinuation of exercise but may last up to 10 minutes or even longer after very strenuous exercise. Anginal pain provoked by emotion may be relieved more slowly than that provoked by physical exercise.

 

Differential diagnosis of the symptoms

If all the above mentioned cardinal features are present, or even only the first two are quite typical, then the diagnosis of chronic stable angina is virtually assured. Often, however, the picture is not so clear-cut and other diagnoses must be considered. Chief amongst these are
  • Esophageal reflux and spasm
  • Peptic ulcer
  • Gallstones
  • Musculoskeletal disorders
  • Non-specific chest pains often associated with anxiety states
  • Coronary artery spasm
  • Myocardial infarction (Here pain is more prolonged i.e. lasts for more than 30 minutes, and is often associated with sweating and systemic symptoms)

 

Investigations for confirming diagnosis
 
  1. Resting electrocardiogram (ECG)
  2. ECG stress testing
  3. Ambulatory ECG monitoring (Holter monitoring)
  4. Echocardiography at rest
  5. Stress echocardiography
  6. Myocardial perfusion scintigraphy
  7. Radionuclide angiography during exercise
  8. Coronary angiography
  9. Intravascular ultrasound

 

Treatment

Life style changes, drugs and interventional techniques all play a part in the treatment of angina pectoris

Aims of treatment
 
  1. To improve prognosis by preventing myocardial infarction and death
  2. To minimize or abolish symptoms

 

General management
 
  • Stop smoking
  • Limit alcohol intake
  • Lose weight, if overweight
  • Increase physical activity within the patient’s limitation
  • Limit intake of food rich in fat and cholesterol. Encourage a high intake of fruits and vegetables
  • Control stress and use relaxation techniques 
  • Control other concomitant disorders such as diabetes, hypertension and anaemia

 

Drug therapy

For prevention of myocardial infarction (MI) and death
  • Use lipid lowering drugs: All patients with angina pectoris should have a lipid profile done. Diet modification and use of lipid lowering drugs are indicated for lowering total cholesterol to below 200 mg/dl and LDL cholesterol to below 100 mg/dl. All patients with angina pectoris should be prescribed lipid lowering drugs if they have an abnormal lipid profile (LDL cholesterol >100 mg/dl).
  • Reduce risk of thrombosis: Aspirin, if not contraindicated, should be administered routinely to all patients of angina.

For symptom relief

  • Nitrates: e.g. nitroglycerin, isosorbide dinitrate. Sublingual and spray formulations of nitrates provide rapid relief of symptoms and are used for treatment of acute attacks of angina pectoris. Oral and transdermal formulations of nitrates are used to prevent anginal attacks and should be taken regularly.
  • Beta blockers: e.g. atenolol, metoprolol
  • Calcium channel blockers: e.g. diltiazem, verapamil (non-dihydropyridine calcium channel blockers), amlodipine (dihydropyridine calcium channel blockers).
  • Cytoprotective drugs: e.g. trimetazidine
  • Potassium channel openers: e.g. nicorandil

 

Page  1  2